The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Open accessAbstract
The transcriptional co‐activators YAP (or YAP1) and TAZ (or WWTR1) are frequently activated during the growth and progression of many solid tumors, including lung, colorectal, breast, pancreatic, and liver carcinomas as well as melanoma and glioma. YAP/TAZ bind to TEAD‐family co‐activators to drive cancer cell survival, proliferation, invasive migration, and metastasis. YAP/TAZ activation may also confer resistance to chemotherapy, radiotherapy, or immunotherapy. YAP‐TEAD cooperates with the RAS‐induced AP‐1 (FOS/JUN) transcription factor to drive tumor growth and cooperates with MRTF‐SRF to promote activation of cancer‐associated fibroblasts, matrix stiffening, and metastasis. The key upstream repressor of YAP/TAZ activation is the Hippo (MST1/2‐LATS1/2) pathway and the key upstream activators are mechanically induced Integrin‐SRC and E‐cadherin‐AJUBA/TRIP6/LIMD1, growth factor induced PI3K‐AKT, and inflammation‐induced G‐protein coupled receptor (GPCR) signals, all of which antagonize the Hippo pathway. In this review, strategies to target YAP/TAZ activity in cancer are discussed along with the prospects for synergy with established pillars of cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, L., Shi, S., Guo, Z., Zhang, X., Han, S., Yang, A., Wen, W., & Zhu, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065539 · Cited by 267
RetractedZhang, X., Li, Y., Ma, Y., Yang, L., Wang, T., Meng, X., Zong, Z., Sun, X., Hua, X., & Li, H. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0892-2 · Cited by 234
RetractedTargeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
The JAK-STAT Pathway at Twenty
Stark, G. R., & Darnell, J. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.013 · Cited by 1,517
Linking Colorectal Cancer to Wnt Signaling
Bienz, M., & Clevers, H. (2000) · Cell · doi:10.1016/s0092-8674(00)00122-7 · Cited by 1,515
Force triggers YAP nuclear entry by regulating transport across nuclear pores
Elosegui-Artola, A., Andreu, I., Beedle, A. E. M., Lezamiz, A., Uroz, M., Kosmalska, A. J., Oria, R., Kechagia, J. Z., Rico-Lastres, P., Le Roux, A.-L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.008 · Cited by 1,491
Calvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S. I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2756 · Cited by 1,478
Mutations in GNA11 in Uveal Melanoma
Van Raamsdonk, C. D., Griewank, K. G., Crosby, M. B., Garrido, M. C., Vemula, S., Wiesner, T., Obenauf, A. C., Wackernagel, W., Green, G., Bouvier, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000584 · Cited by 1,476
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
Actin dynamics control SRF activity by regulation of its coactivator MAL
Miralles, F., Posern, G., Zaromytidou, A.-I., & Treisman, R. (2003) · Cell · doi:10.1016/s0092-8674(03)00278-2 · Cited by 1,327
The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF
Hill, C. S., Wynne, J., & Treisman, R. (1995) · Cell · doi:10.1016/s0092-8674(05)80020-0 · Cited by 1,269
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Zanconato, F., Forcato, M., Battilana, G., Azzolin, L., Quaranta, E., Bodega, B., Rosato, A., Bicciato, S., Cordenonsi, M., & Piccolo, S. (2015) · Nature Cell Biology · doi:10.1038/ncb3216 · Cited by 1,219
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Integrin-mediated mechanotransduction
Sun, Z., Guo, S. S., & Fässler, R. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201609037 · Cited by 1,079
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Alveolar progenitor and stem cells in lung development, renewal and cancer
Desai, T. J., Brownfield, D. G., & Krasnow, M. A. (2014) · Nature · doi:10.1038/nature12930 · Cited by 1,060
Hippo signaling: growth control and beyond
Halder, G., & Johnson, R. L. (2011) · Development · doi:10.1242/dev.045500 · Cited by 1,060
Yap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036
Linking actin dynamics and gene transcription to drive cellular motile functions
Olson, E. N., & Nordheim, A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2890 · Cited by 958
Norman, C., Runswick, M., Pollock, R., & Treisman, R. (1988) · Cell · doi:10.1016/0092-8674(88)90244-9 · Cited by 957
Lei, Q.-Y., Zhang, H., Zhao, B., Zha, Z.-Y., Bai, F., Pei, X.-H., Zhao, S., Xiong, Y., & Guan, K.-L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01874-07 · Cited by 924
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
Hippo pathway effector Yap promotes cardiac regeneration
Xin, M., Kim, Y., Sutherland, L. B., Murakami, M., Qi, X., McAnally, J., Porrello, E. R., Mahmoud, A. I., Tan, W., Shelton, J. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313192110 · Cited by 895
Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon
Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C.-X., Brugge, J. S., & Haber, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605579103 · Cited by 885
Adhesion signaling – crosstalk between integrins, Src and Rho
Huveneers, S., & Danen, E. H. J. (2009) · Journal of Cell Science · doi:10.1242/jcs.039446 · Cited by 852
Hippo pathway regulation by cell morphology and stress fibers
Wada, K.-I., Itoga, K., Okano, T., Yonemura, S., & Sasaki, H. (2011) · Development · doi:10.1242/dev.070987 · Cited by 849
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
Genetic and cell biological analysis of integrin outside-in signaling
Legate, K. R., Wickström, S. A., & Fässler, R. (2009) · Genes & Development · doi:10.1101/gad.1758709 · Cited by 802
Miyamoto, S., Teramoto, H., Gutkind, J. S., & Yamada, K. M. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1633 · Cited by 760
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Rosenbluh, J., Nijhawan, D., Cox, A. G., Li, X., Neal, J. T., Schafer, E. J., Zack, T. I., Wang, X., Tsherniak, A., Schinzel, A. C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.026 · Cited by 757
Kanai, F., Marignani, P. A., Sarbassova, D., Yagi, R., Hall, R. A., Donowitz, M., Hisaminato, A., Fujiwara, T., Ito, Y., Cantley, L. C., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6778 · Cited by 756
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Shao, D. D., Xue, W., Krall, E. B., Bhutkar, A., Piccioni, F., Wang, X., Schinzel, A. C., Sood, S., Rosenbluh, J., Kim, J. W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.004 · Cited by 744
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G., Finegold, M. J., Lee, J.-S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911427107 · Cited by 721
Vassilev, A., Kaneko, K. J., Shu, H., Zhao, Y., & DePamphilis, M. L. (2001) · Genes & Development · doi:10.1101/gad.888601 · Cited by 719
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Kapoor, A., Yao, W., Ying, H., Hua, S., Liewen, A., Wang, Q., Zhong, Y., Wu, C.-J., Sadanandam, A., Hu, B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.003 · Cited by 716
Alternative Wnt Signaling Activates YAP/TAZ
Park, H. W., Kim, Y. C., Yu, B., Moroishi, T., Mo, J.-S., Plouffe, S. W., Meng, Z., Lin, K. C., Yu, F.-X., Alexander, C. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.013 · Cited by 705
YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration
Yui, S., Azzolin, L., Maimets, M., Pedersen, M. T., Fordham, R. P., Hansen, S. L., Larsen, H. L., Guiu, J., Alves, M. R. P., Rundsten, C. F., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.001 · Cited by 681
Signal-Regulated Activation of Serum Response Factor Is Mediated by Changes in Actin Dynamics
Sotiropoulos, A., Gineitis, D., Copeland, J., & Treisman, R. (1999) · Cell · doi:10.1016/s0092-8674(00)81011-9 · Cited by 655
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
Lamar, J. M., Stern, P., Liu, H., Schindler, J. W., Jiang, Z.-G., & Hynes, R. O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212021109 · Cited by 654
Biscardi, J. S., Maa, M.-C., Tice, D. A., Cox, M. E., Leu, T.-H., & Parsons, S. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8335 · Cited by 649
Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer
Gregorieff, A., Liu, Y., Inanlou, M. R., Khomchuk, Y., & Wrana, J. L. (2015) · Nature · doi:10.1038/nature15382 · Cited by 648
Wu, S., Liu, Y., Zheng, Y., Dong, J., & Pan, D. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.007 · Cited by 640
A gp130–Src–YAP module links inflammation to epithelial regeneration
Taniguchi, K., Wu, L.-W., Grivennikov, S. I., de Jong, P. R., Lian, I., Yu, F.-X., Wang, K., Ho, S. B., Boland, B. S., Chang, J. T., et al. (2015) · Nature · doi:10.1038/nature14228 · Cited by 633
The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control
Zhang, L., Ren, F., Zhang, Q., Chen, Y., Wang, B., & Jiang, J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.006 · Cited by 630
E-cadherin–integrin crosstalk in cancer invasion and metastasis
Canel, M., Serrels, A., Frame, M. C., & Brunton, V. G. (2013) · Journal of Cell Science · doi:10.1242/jcs.100115 · Cited by 623
Nuclear Actin Regulates Dynamic Subcellular Localization and Activity of the SRF Cofactor MAL
Vartiainen, M. K., Guettler, S., Larijani, B., & Treisman, R. (2007) · Science · doi:10.1126/science.1141084 · Cited by 622
Regulation of E-cadherin/Catenin Association by Tyrosine Phosphorylation
Roura, S., Miravet, S., Piedra, J., de Herreros, A. G., & Duñach, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36734 · Cited by 603
Novel YAP1‐TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma
Antonescu, C. R., Le Loarer, F., Mosquera, J., Sboner, A., Zhang, L., Chen, C., Chen, H., Pathan, N., Krausz, T., Dickson, B. C., et al. (2013) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.22073 · Cited by 597
Moro, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6622 · Cited by 584
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Song, H., Mak, K. K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., Simpson, R. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911409107 · Cited by 583
Zhang, H., Liu, C.-Y., Zha, Z.-Y., Zhao, B., Yao, J., Zhao, S., Xiong, Y., Lei, Q.-Y., & Guan, K.-L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900843200 · Cited by 569
A WW domain-containing Yes-associated protein (YAP) is a novel transcriptional co-activator
Yagi, R., Chen, L.-F., Shigesada, K., Murakami, Y., & Ito, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2551 · Cited by 558
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Wang, G., Lu, X., Dey, P., Deng, P., Wu, C. C., Jiang, S., Fang, Z., Zhao, K., Konaparthi, R., Hua, S., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0224 · Cited by 553
Restriction of intestinal stem cell expansion and the regenerative response by YAP
Barry, E. R., Morikawa, T., Butler, B. L., Shrestha, K., de la Rosa, R., Yan, K. S., Fuchs, C. S., Magness, S. T., Smits, R., Ogino, S., et al. (2013) · Nature · doi:10.1038/nature11693 · Cited by 543
The Extracellular Matrix Modulates the Metastatic Journey
Kai, F., Drain, A. P., & Weaver, V. M. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.03.026 · Cited by 537
Benham-Pyle, B. W., Pruitt, B. L., & Nelson, W. J. (2015) · Science · doi:10.1126/science.aaa4559 · Cited by 534
Actin’ together: serum response factor, its cofactors and the link to signal transduction
Posern, G., & Treisman, R. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.09.008 · Cited by 527
Plopper, G. E., McNamee, H. P., Dike, L. E., Bojanowski, K., & Ingber, D. E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.10.1349 · Cited by 504
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Wang, Y., Xu, X., Maglic, D., Dill, M. T., Mojumdar, K., Ng, P. K.-S., Jeong, K. J., Tsang, Y. H., Moreno, D., Bhavana, V. H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.001 · Cited by 500
Lee, K.-P., Lee, J.-H., Kim, T.-S., Kim, T.-H., Park, H.-D., Byun, J.-S., Kim, M.-C., Jeong, W.-I., Calvisi, D. F., Kim, J.-M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912203107 · Cited by 493
The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program
Cai, J., Zhang, N., Zheng, Y., de Wilde, R. F., Maitra, A., & Pan, D. (2010) · Genes & Development · doi:10.1101/gad.1978810 · Cited by 492
A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells
Chan, S. W., Lim, C. J., Guo, K., Ng, C. P., Lee, I., Hunziker, W., Zeng, Q., & Hong, W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2696 · Cited by 478
Wang, D.-Z., Li, S., Hockemeyer, D., Sutherland, L., Wang, Z., Schratt, G., Richardson, J. A., Nordheim, A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222561499 · Cited by 474
Buchanan, F. G., Wang, D., Bargiacchi, F., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302474200 · Cited by 463
Gschwind, A., Zwick, E., Prenzel, N., Leserer, M., & Ullrich, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204192 · Cited by 462
Hippo signaling impedes adult heart regeneration
Heallen, T., Morikawa, Y., Leach, J., Tao, G., Willerson, J. T., Johnson, R. L., & Martin, J. F. (2013) · Development · doi:10.1242/dev.102798 · Cited by 458
Gβγ Subunits Mediate Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor
Luttrell, L. M., Rocca, G. J. D., van Biesen, T., Luttrell, D. K., & Lefkowitz, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4637 · Cited by 457
Zhou, D., Zhang, Y., Wu, H., Barry, E., Yin, Y., Lawrence, E., Dawson, D., Willis, J. E., Markowitz, S. D., Camargo, F. D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110428108 · Cited by 453
Adhesion to fibronectin regulates Hippo signaling via the FAK–Src–PI3K pathway
Kim, N.-G., & Gumbiner, B. M. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201501025 · Cited by 421
Zhang, H., Pasolli, H. A., & Fuchs, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019603108 · Cited by 419
Medjkane, S., Perez-Sanchez, C., Gaggioli, C., Sahai, E., & Treisman, R. (2009) · Nature Cell Biology · doi:10.1038/ncb1833 · Cited by 415
Chen, D., Sun, Y., Wei, Y., Zhang, P., Rezaeian, A. H., Teruya-Feldstein, J., Gupta, S., Liang, H., Lin, H.-K., Hung, M.-C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2940 · Cited by 413
(1994) · PubMed · Cited by 404
Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation
Lee, C.-K., Jeong, S.-H., Jang, C., Bae, H., Kim, Y. H., Park, I., Kim, S. K., & Koh, G. Y. (2019) · Science · doi:10.1126/science.aav0173 · Cited by 400
Thompson, B. J., & Cohen, S. M. (2006) · Cell · doi:10.1016/j.cell.2006.07.013 · Cited by 398
Self-citationYAP regulates neural progenitor cell number via the TEA domain transcription factor
Cao, X., Pfaff, S. L., & Gage, F. H. (2008) · Genes & Development · doi:10.1101/gad.1726608 · Cited by 397
YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation
Kim, J., Kim, Y. H., Kim, J., Park, D. Y., Bae, H., Lee, D.-H., Kim, K. H., Hong, S. P., Jang, S. P., Kubota, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93825 · Cited by 390
Moro, L., Dolce, L., Cabodi, S., Bergatto, E., Erba, E. B., Smeriglio, M., Turco, E., Retta, S. F., Giuffrida, M. G., Venturino, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109101200 · Cited by 377
Serum response factor is essential for mesoderm formation during mouse embryogenesis
Arsenian, S., Weinhold, B., Oelgeschläger, M., Rüther, U., & Nordheim, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6289 · Cited by 372
Zhang, W., Nandakumar, N., Shi, Y., Manzano, M., Smith, A., Graham, G., Gupta, S., Vietsch, E. E., Laughlin, S. Z., Wadhwa, M., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005049 · Cited by 360
Cytoskeletal Tension Inhibits Hippo Signaling through an Ajuba-Warts Complex
Rauskolb, C., Sun, S., Sun, G., Pan, Y., & Irvine, K. D. (2014) · Cell · doi:10.1016/j.cell.2014.05.035 · Cited by 353
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
Bartucci, M., Dattilo, R., Moriconi, C., Pagliuca, A., Mottolese, M., Federici, G., Benedetto, A. D., Todaro, M., Stassi, G., Sperati, F., et al. (2015) · Oncogene · doi:10.1038/onc.2014.5 · Cited by 350
Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma
Chen, P., Zhao, D., Li, J., Liang, X., Li, J., Chang, A., Henry, V. K., Lan, Z., Spring, D. J., Rao, G., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.05.003 · Cited by 339
Fan, R., Kim, N.-G., & Gumbiner, B. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216462110 · Cited by 336
Force activates smooth muscle α-actin promoter activity through the Rho signaling pathway
Zhao, X.-H., Laschinger, C., Arora, P., Szászi, K., Kapus, A., & McCulloch, C. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.001586 · Cited by 329
Phosphatidylinositol 3-kinase, growth disorders, and cancer
Goncalves, M. D., Hopkins, B. D., & Cantley, L. C. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1704560 · Cited by 327
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., AOCS Study group, Bowtell, D. D. L., & Harvey, K. F. (2011) · Oncogene · doi:10.1038/onc.2011.8 · Cited by 309
Tsukita, S., Oishi, K., Akiyama, T., Yamanashi, Y., Yamamoto, T., & Tsukita, S. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.4.867 · Cited by 308
The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
Janse van Rensburg, H. J., Azad, T., Ling, M., Hao, Y., Snetsinger, B., Khanal, P., Minassian, L. M., Graham, C. H., Rauh, M. J., & Yang, X. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3139 · Cited by 306
Evidence for type II cells as cells of origin of K-Ras–induced distal lung adenocarcinoma
Xu, X., Rock, J. R., Lu, Y., Futtner, C., Schwab, B., Guinney, J., Hogan, B. L. M., & Onaitis, M. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112499109 · Cited by 303
Src family kinases: at the forefront of platelet activation
Senis, Y. A., Mazharian, A., & Mori, J. (2014) · Blood · doi:10.1182/blood-2014-01-453134 · Cited by 296
Integrin signalling regulates YAP/TAZ to control skin homeostasis
Elbediwy, A., Vincent-Mistiaen, Z. I., Spencer-Dene, B., Stone, R. K., Boeing, S., Wculek, S. K., Cordero, J., Tan, E. H., Ridgway, R., Brunton, V. G., et al. (2016) · Development · doi:10.1242/dev.133728 · Cited by 291
Self-citationYap/Taz regulate alveolar regeneration and resolution of lung inflammation
LaCanna, R., Liccardo, D., Zhang, P., Tragesser, L., Wang, Y., Cao, T., Chapman, H. A., Morrisey, E. E., Shen, H., Koch, W. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125014 · Cited by 288
Neto-Silva, R. M., de Beco, S., & Johnston, L. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.009 · Cited by 287
Single tumor-initiating cells evade immune clearance by recruiting type II macrophages
Guo, X., Zhao, Y., Yan, H., Yang, Y., Shen, S., Dai, X., Ji, X., Ji, F., Gong, X.-G., Li, L., et al. (2017) · Genes & Development · doi:10.1101/gad.294348.116 · Cited by 285
Koontz, L. M., Liu-Chittenden, Y., Yin, F., Zheng, Y., Yu, J., Huang, B., Chen, Q., Wu, S., & Pan, D. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.04.021 · Cited by 283
Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs)
Mo, J.-S., Yu, F.-X., Gong, R., Brown, J. H., & Guan, K.-L. (2012) · Genes & Development · doi:10.1101/gad.197582.112 · Cited by 282
Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
Ma, B., Chen, Y., Chen, L., Cheng, H., Mu, C., Li, J., Gao, R., Zhou, C., Cao, L., Liu, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3073 · Cited by 266
The bantam MicroRNA Is a Target of the Hippo Tumor-Suppressor Pathway
Nolo, R., Morrison, C. M., Tao, C., Zhang, X., & Halder, G. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.057 · Cited by 265
Ahn, S., Maudsley, S., Luttrell, L. M., Lefkowitz, R. J., & Daaka, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1185 · Cited by 263
Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Hall, C. A., Wang, R., Miao, J., Oliva, E., Shen, X., Wheeler, T., Hilsenbeck, S. G., Orsulic, S., & Goode, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1242 · Cited by 263
Morita, T., Mayanagi, T., & Sobue, K. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200708174 · Cited by 262
Ajuba LIM Proteins Are Negative Regulators of the Hippo Signaling Pathway
Das Thakur, M., Feng, Y., Jagannathan, R., Seppa, M. J., Skeath, J. B., & Longmore, G. D. (2010) · Current Biology · doi:10.1016/j.cub.2010.02.035 · Cited by 258
Neto, F., Klaus-Bergmann, A., Ong, Y. T., Alt, S., Vion, A.-C., Szymborska, A., Carvalho, J. R., Hollfinger, I., Bartels-Klein, E., Franco, C. A., et al. (2018) · eLife · doi:10.7554/elife.31037 · Cited by 255
YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
Kim, M. H., Kim, C. G., Kim, S.-K., Shin, S. J., Choe, E. A., Park, S.-H., Shin, E.-C., & Kim, J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0320 · Cited by 241
Feng, X., Arang, N., Rigiracciolo, D. C., Lee, J. S., Yeerna, H., Wang, Z., Lubrano, S., Kishore, A., Pachter, J. A., König, G. M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.009 · Cited by 237
MAPK-Mediated YAP Activation Controls Mechanical-Tension-Induced Pulmonary Alveolar Regeneration
Liu, Z., Wu, H., Jiang, K., Wang, Y., Zhang, W., Chu, Q., Li, J., Huang, H., Cai, T., Ji, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.020 · Cited by 236
Marti, P., Stein, C., Blumer, T., Abraham, Y., Dill, M. T., Pikiolek, M., Orsini, V., Jurisic, G., Megel, P., Makowska, Z., et al. (2015) · Hepatology · doi:10.1002/hep.27992 · Cited by 232
Hiemer, S. E., Szymaniak, A. D., & Varelas, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529115 · Cited by 227
YAP is a candidate oncogene for esophageal squamous cell carcinoma
Muramatsu, T., Imoto, I., Matsui, T., Kozaki, K.-I., Haruki, S., Sudol, M., Shimada, Y., Tsuda, H., Kawano, T., & Inazawa, J. (2011) · Carcinogenesis · doi:10.1093/carcin/bgq254 · Cited by 227
Chen, Q., Zhang, N., Gray, R. S., Li, H., Ewald, A. J., Zahnow, C. A., & Pan, D. (2014) · Genes & Development · doi:10.1101/gad.233676.113 · Cited by 219
Gruber, R., Panayiotou, R., Nye, E., Spencer-Dene, B., Stamp, G., & Behrens, A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.006 · Cited by 218
Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma
Murakami, S., Shahbazian, D., Surana, R., Zhang, W., Chen, H., Graham, G. T., White, S. M., Weiner, L. M., & Yi, C. (2017) · Oncogene · doi:10.1038/onc.2016.288 · Cited by 215
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
Chaib, I., Karachaliou, N., Pilotto, S., Codony Servat, J., Cai, X., Li, X., Drozdowskyj, A., Servat, C. C., Yang, J., Hu, C., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx014 · Cited by 210
Pobbati, A. V., Han, X., Hung, A. W., Weiguang, S., Huda, N., Chen, G.-Y., Kang, C., Chia, C. S. B., Luo, X., Hong, W., et al. (2015) · Structure · doi:10.1016/j.str.2015.09.009 · Cited by 206
YAP/TAZ-CDC42 signaling regulates vascular tip cell migration
Sakabe, M., Fan, J., Odaka, Y., Liu, N., Hassan, A., Duan, X., Stump, P., Byerly, L., Donaldson, M., Hao, J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704030114 · Cited by 203
Foster, C. T., Gualdrini, F., & Treisman, R. (2017) · Genes & Development · doi:10.1101/gad.304501.117 · Cited by 202
Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis
Lau, A. N., Curtis, S. J., Fillmore, C. M., Rowbotham, S. P., Mohseni, M., Wagner, D. E., Beede, A. M., Montoro, D. T., Sinkevicius, K. W., Walton, Z. E., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201386082 · Cited by 202
Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration
Lu, L., Finegold, M. J., & Johnson, R. L. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.205 · Cited by 190
Ziosi, M., Baena-López, L. A., Grifoni, D., Froldi, F., Pession, A., Garoia, F., Trotta, V., Bellosta, P., Cavicchi, S., & Pession, A. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001140 · Cited by 184
Evidence for Tension-Based Regulation of Drosophila MAL and SRF during Invasive Cell Migration
Somogyi, K., & Rørth, P. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.05.020 · Cited by 184
Bill, H. M., Knudsen, B., Moores, S. L., Muthuswamy, S. K., Rao, V. R., Brugge, J. S., & Miranti, C. K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8586-8599.2004 · Cited by 183
Li, P., Silvis, M. R., Honaker, Y., Lien, W.-H., Arron, S. T., & Vasioukhin, V. (2016) · Genes & Development · doi:10.1101/gad.274951.115 · Cited by 180
Tremblay, A. M., Missiaglia, E., Galli, G. G., Hettmer, S., Urcia, R., Carrara, M., Judson, R. N., Thway, K., Nadal, G., Selfe, J. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.029 · Cited by 178
Src and focal adhesion kinase as therapeutic targets in cancer
Brunton, V. G., & Frame, M. C. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.012 · Cited by 177
Cai, J., Maitra, A., Anders, R. A., Taketo, M. M., & Pan, D. (2015) · Genes & Development · doi:10.1101/gad.264515.115 · Cited by 175
Fan, L., Sebe, A., Péterfi, Z., Masszi, A., Thirone, A. C. P., Rotstein, O. D., Nakano, H., McCulloch, C. A., Szászi, K., Mucsi, I., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0602 · Cited by 173
Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer
Jeong, S.-H., Kim, H.-B., Kim, M.-C., Lee, J.-M., Lee, J. H., Kim, J.-H., Kim, J.-W., Park, W.-Y., Kim, S.-Y., Kim, J. B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95802 · Cited by 172
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
Lamar, J. M., Xiao, Y., Norton, E., Jiang, Z.-G., Gerhard, G. M., Kooner, S., Warren, J. S. A., & Hynes, R. O. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004364 · Cited by 169
Xia, Y., Chang, T., Wang, Y., Liu, Y., Li, W., Li, M., & Fan, H.-Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091770 · Cited by 167
Davie, K., Jacobs, J., Atkins, M., Potier, D., Christiaens, V., Halder, G., & Aerts, S. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004994 · Cited by 166
Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma
Mainardi, S., Mijimolle, N., Francoz, S., Vicente-Dueñas, C., Sánchez-García, I., & Barbacid, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320383110 · Cited by 164
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Warren, J., Xiao, Y., & Lamar, J. (2018) · Cancers · doi:10.3390/cancers10040115 · Cited by 164
Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
Adams, J. R., Xu, K., Liu, J. C., Agamez, N. M. R., Loch, A. J., Wong, R. G., Wang, W., Wright, K. L., Lane, T. F., Zacksenhaus, E., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0738 · Cited by 163
Guettler, S., Vartiainen, M. K., Miralles, F., Larijani, B., & Treisman, R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01623-07 · Cited by 163
Zhang, L., Yang, S., Chen, X., Stauffer, S., Yu, F., Lele, S. M., Fu, K., Datta, K., Palermo, N., Chen, Y., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00102-15 · Cited by 161
Petkov, V. I., Miller, D. P., Howlader, N., Gliner, N., Howe, W., Schussler, N. C., Cronin, K. A., Baehner, F. L., Cress, R. D., Deapen, D., et al. (2016) · npj Breast Cancer · doi:10.1038/npjbcancer.2016.17 · Cited by 161
Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression
New, D. C., & Wong, Y. H. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-2 · Cited by 155
YAP is a critical oncogene in human cholangiocarcinoma
Pei, T., Li, Y., Wang, J., Wang, H., Liang, Y., Shi, H., Sun, B., Yin, D., Sun, J., Song, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4043 · Cited by 154
Feng, Y., Liang, Y., Zhu, X., Wang, M., Gui, Y., Lu, Q., Gu, M., Xue, X., Sun, X., He, W., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005457 · Cited by 152
Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP
Straßburger, K., Tiebe, M., Pinna, F., Breuhahn, K., & Teleman, A. A. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.05.008 · Cited by 151
Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
Nallet-Staub, F., Marsaud, V., Li, L., Gilbert, C., Dodier, S., Bataille, V. A., Sudol, M., Herlyn, M., & Mauviel, A. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.319 · Cited by 150
E-Cadherin Adhesion Activates c-Src Signaling at Cell–Cell Contacts
McLachlan, R. W., Kraemer, A., Helwani, F., Kovács, É., & Yap, A. S. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1154 · Cited by 149
Keely, S. J., Calandrella, S. O., & Barrett, K. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12619 · Cited by 145
Kim, H.-B., Kim, M., Park, Y.-S., Park, I., Kim, T., Yang, S. Y., Cho, C. J., Hwang, D., Jung, J., Markowitz, S. D., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.11.005 · Cited by 144
Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1
Si, Y., Ji, X., Cao, X., Dai, X., Xu, L., Zhao, H., Guo, X., Yan, H., Zhang, H., Zhu, C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0391 · Cited by 142
Regulation of the Hippo pathway by cell architecture and mechanical signals
Schroeder, M. C., & Halder, G. A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.06.001 · Cited by 140
A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma
Hiemer, S. E., Zhang, L., Kartha, V. K., Packer, T. S., Almershed, M., Noonan, V. L., Kukuruzinska, M. A., Bais, M. V., Monti, S., & Varelas, X. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0580 · Cited by 139
Li, N., Feng, Y., Hu, Y., He, C., Xie, C., Ouyang, Y., Artim, S. C., Huang, D., Zhu, Y., Luo, Z., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0962-5 · Cited by 137
Ram, P. T., & Iyengar, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204186 · Cited by 133
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
Ciamporcero, E. S., Shen, H., Ramakrishnan, S., Ku, S., Chintala, S., Shen, L., Adelaiye-Ogala, R. M., Miles, K. M., Ullio, C., Pizzimenti, S., et al. (2015) · Oncogene · doi:10.1038/onc.2015.219 · Cited by 129
Lucas, E. P., Khanal, I., Gaspar, P., Fletcher, G., Polesello, C., Tapon, N., & Thompson, B. J. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201210073 · Cited by 129
Self-citationXia, H., Dai, X., Yu, H., Zhou, S., Fan, Z., Wei, G., Tang, Q., Gong, Q., & Bi, F. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0302-x · Cited by 129
Liu, J.-Y., Li, Y.-H., Lin, H., Liao, Y.-J., Mai, S., Liu, Z.-W., Zhang, Z.-L., Jiang, L.-J., Zhang, J., Kung, H., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-349 · Cited by 126
White, S. M., Avantaggiati, M. L., Nemazanyy, I., Poto, C. D., Yang, Y., Pende, M., Gibney, G. T., Ressom, H. W., Field, J., Atkins, M. B., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.014 · Cited by 126
EGF Receptor–Dependent YAP Activation Is Important for Renal Recovery from AKI
Chen, J., You, H., Li, Y., You, X., Qian, H., & Harris, R. C. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017121272 · Cited by 125
Abali, G. K., Alptekin, A., Lewis, M. S., Garraway, I. P., & Cinar, B. (2015) · Nature Communications · doi:10.1038/ncomms9126 · Cited by 122
Doggett, K., Grusche, F. A., Richardson, H. E., & Brumby, A. M. (2011) · BMC Developmental Biology · doi:10.1186/1471-213x-11-57 · Cited by 119
Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer
Holla, V. R., Mann, J. R., Shi, Q., & DuBois, R. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507752200 · Cited by 118
Elbediwy, A., Vincent‐Mistiaen, Z. I., & Thompson, B. J. (2016) · BioEssays · doi:10.1002/bies.201600037 · Cited by 117
Self-citationFeng, X., Liu, P., Zhou, X., Li, M.-T., Li, F.-L., Wang, Z., Meng, Z., Sun, Y.-P., Yu, Y., Xiong, Y., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739722 · Cited by 115
MRTF potentiates TEAD‐YAP transcriptional activity causing metastasis
Kim, T., Hwang, D., Lee, D., Kim, J., Kim, S., & Lim, D. (2017) · The EMBO Journal · doi:10.15252/embj.201695137 · Cited by 114
GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi
Vader, M., Madigan, M. C., Versluis, M., Suleiman, H. M., Gezgin, G., Gruis, N. A., Out‐Luiting, J. J., Bergman, W., Verdijk, R. M., Jager, M. J., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.259 · Cited by 110
Sugihara, T., Werneburg, N. W., Hernandez, M. C., Yang, L., Kabashima, A., Hirsova, P., Yohanathan, L., Sosa, C., Truty, M. J., Vasmatzis, G., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0158 · Cited by 110
Dasari, V. R., Mazack, V., Feng, W., Nash, J. D., Carey, D. J., & Gogoi, R. P. (2017) · Oncotarget · doi:10.18632/oncotarget.15614 · Cited by 108
Walko, G., Woodhouse, S., Pisco, A. O., Rognoni, E., Liakath‐Ali, K., Lichtenberger, B. M., Mishra, A., Telerman, S. B., Viswanathan, P., Logtenberg, M. E. W., et al. (2017) · Nature Communications · doi:10.1038/ncomms14744 · Cited by 105
Yu, M., Chen, Y., Li, X., Yang, R., Zhang, L., Huangfu, L., Zheng, N., Zhao, X., Lv, L., Hong, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0515-z · Cited by 105
Yokoyama, T., Osada, H., Murakami, H., Tatematsu, Y., Taniguchi, T., Kondo, Y., Yatabe, Y., Hasegawa, Y., Shimokata, K., Horio, Y., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn200 · Cited by 103
Yu, O. M., Miyamoto, S., & Brown, J. H. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00772-15 · Cited by 100
Morvaridi, S., Dhall, D., Greene, M. I., Pandol, S. J., & Wang, Q. (2015) · Scientific Reports · doi:10.1038/srep16759 · Cited by 100
Mechanical strain regulates the Hippo pathway in Drosophila
Fletcher, G., Díaz-de-la-Loza, M.-D.-C., Borreguero-Muñoz, N., Holder, M. V., Aguilar‐Aragon, M., & Thompson, B. J. (2018) · Development · doi:10.1242/dev.159467 · Cited by 100
Self-citationTissue Transglutaminase Mediated Tumor–Stroma Interaction Promotes Pancreatic Cancer Progression
Lee, J., Condello, S., Yakubov, B., Emerson, R. E., Caperell–Grant, A., Hitomi, K., Xie, J., & Matei, D. E. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0226 · Cited by 97
Zhang, W., Gao, Y., Li, F., Tong, X., Ren, Y., Han, X., Yao, S., Long, F., Yang, Z., Fan, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3396 · Cited by 96
YAP–IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis
Taniguchi, K., Moroishi, T., de Jong, P. R., Krawczyk, M., Grebbin, B. M., Luo, H., Xu, R., Golob‐Schwarzl, N., Schweiger, C., Wang, K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620290114 · Cited by 96
Ling, H., Kuo, C.-C., Lin, B.-X., Huang, Y., & Lin, C. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.024 · Cited by 94
Herranz, H., Hong, X., & Cohen, S. M. (2012) · Current Biology · doi:10.1016/j.cub.2012.02.050 · Cited by 93
Ciamporcero, E. S., Daga, M., Pizzimenti, S., Roetto, A., Dianzani, C., Compagnone, A., Palmieri, A., Ullio, C., Cangemi, L., Пили, Р., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.005 · Cited by 93
Patel, N. R., Salim, A. A., Sayeed, H., et al. (2015) · Histopathology · doi:10.1111/his.12697 · Cited by 89
Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis
Greenhough, A., Bagley, C., Heesom, K. J., Gurevich, D., Gay, D. M., Bond, M., Collard, T. J., Paraskeva, C., Martin, P. B., Sansom, O. J., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708699 · Cited by 89
Atkins, M., Potier, D., Romanelli, L., Jacobs, J., Mach, J., Hamaratoglu, F., Aerts, S., & Halder, G. (2016) · Current Biology · doi:10.1016/j.cub.2016.06.035 · Cited by 88
Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway
Liu, G., Yu, F., Kim, Y. C., Meng, Z., Naipauer, J., Looney, D. J., Liu, X., Gutkind, J. S., Mesri, E. A., & Guan, K.-L. (2014) · Oncogene · doi:10.1038/onc.2014.281 · Cited by 86
Yap Controls Stem/Progenitor Cell Proliferation in the Mouse Postnatal Epidermis
Beverdam, A., Claxton, C., Zhang, X., James, G., Harvey, K. F., & Key, B. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.430 · Cited by 85
YAP/TEAD Co-Activator Regulated Pluripotency and Chemoresistance in Ovarian Cancer Initiated Cells
Xia, Y., Zhang, Y., Yu, C. Y., Chang, T., & Fan, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109575 · Cited by 84
EGFR family and Src family kinase interactions: mechanics matters?
Chen, Z., Oh, D., Dubey, A. K., Yao, M., Yang, B., Groves, J. T., & Sheetz, M. P. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.12.003 · Cited by 84
Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway
Dong, L., Fan, L., Wu, W., Liu, Y., & Huang, W. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.23460 · Cited by 82
Serrels, A., Canel, M., Brunton, V. G., & Frame, M. C. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.4.17290 · Cited by 81
Yoshikawa, K., Noguchi, K., Nakano, Y., Yamamura, M., Takaoka, K., Hashimoto-Tamaoki, T., & Kishimoto, H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2948 · Cited by 81
Mayrhofer, M., Gourain, V., Reischl, M., Affaticati, P., Jenett, A., Joly, J., Benelli, M., Demichelis, F., Poliani, P. L., Sieger, D., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.026500 · Cited by 81
Mohun, T. J., Chambers, A., Towers, N., & Taylor, M. V. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08027.x · Cited by 79
Yuan, Y., Li, D., Li, H., Wang, L., TIAN, G., & DONG, Y. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4550 · Cited by 79
Xu, J., Li, P.-X., Wu, J., Gao, Y., Yin, M.-X., Lin, Y., Yang, M., Chen, D., Sun, H., Liu, Z.-B., et al. (2015) · Clinical Science · doi:10.1042/cs20150385 · Cited by 79
Cited by
Insights into recent findings and clinical application of YAP and TAZ in cancer
Franklin, J. M., Wu, Z., & Guan, K.-L. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00579-1 · Cited by 213
Therapeutic targeting of TEAD transcription factors in cancer
Pobbati, A. V., Kumar, R., Rubin, B. P., & Hong, W. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.12.005 · Cited by 147
Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
Nishikawa, S., & Iwakuma, T. (2023) · Cancers · doi:10.3390/cancers15020429 · Cited by 115
Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Hooglugt, A., van der Stoel, M. M., Boon, R. A., & Huveneers, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612802 · Cited by 82
Zhao, W., Yuan, W., Dong, T., Qi, W., Feng, Z., Li, C., & Sun, Y. (2025) · Communications Biology · doi:10.1038/s42003-025-08160-2 · Cited by 16
Metadata
- Authors
- Thompson, B. J.
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 2020-03-04
- Volume
- 42
- Issue
- 5
- Pages
- e1900162-e1900162
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W3009146905
- Cited by
- 259
- References
- 260
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.